TipRanks
Advertisement
Advertisement
Glaukos Corp. Earnings Call Highlights Robust Growth
PremiumCompany AnnouncementsGlaukos Corp. Earnings Call Highlights Robust Growth
2M ago
Glaukos Corp.’s Anti-Takeover Defenses Raise Governance Risk and Potentially Depress Shareholder Value
Premium
Company Announcements
Glaukos Corp.’s Anti-Takeover Defenses Raise Governance Risk and Potentially Depress Shareholder Value
2M ago
Glaukos price target raised to $195 from $168 at H.C. Wainwright
Premium
The Fly
Glaukos price target raised to $195 from $168 at H.C. Wainwright
2M ago
Glaukos price target raised to $195 from $165 at Piper Sandler
PremiumThe FlyGlaukos price target raised to $195 from $165 at Piper Sandler
2M ago
Glaukos price target raised to $188 from $175 at Citi
Premium
The Fly
Glaukos price target raised to $188 from $175 at Citi
2M ago
Glaukos price target raised to $178 from $138 at Wells Fargo
Premium
The Fly
Glaukos price target raised to $178 from $138 at Wells Fargo
2M ago
Glaukos reports Q2 adjusted EPS (14c), consensus (21c)
PremiumThe FlyGlaukos reports Q2 adjusted EPS (14c), consensus (21c)
2M ago
Glaukos assumed with Neutral from Buy at UBS
Premium
The Fly
Glaukos assumed with Neutral from Buy at UBS
2M ago
Glaukos completes patient enrollment in 510k study for PRESERFLO
Premium
The Fly
Glaukos completes patient enrollment in 510k study for PRESERFLO
2M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―